6-Ethyl-3-({3-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl}amino)-5-(tetrahydro-2H-pyran-4-ylamino)-2-pyrazinecarboxamide(CAS: 1254053-43-4)

The chemical is subject to regulatory guidelines under the Chemicals Regulation Directive (CRD) and Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) in the EU. In the US, it falls under the Toxic Substances Control Act (TSCA) and may require reporting to the EPA. Safety data sheets (SDS) should be prepared and maintained according to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) standards.

In synthesis, alternatives such as 6-ethyl-3-(3-methoxy-4-phenylamino-4-(4-methyl-1-piperazinyl)-1-piperidinyl)pyrazine-5-carboxylic acid tetrahydro-2H-pyran-4-ylamide and 6-ethyl-3-(3-methoxy-4-(4-methyl-1-piperazinyl)-1-piperidinyl)phenylamino)-5-carbamoyl)-2-pyrazine carboxylic acid may serve as substitutes. Additionally, using different coupling agents or modifying the synthesis route can also provide alternative options.

The market for 6-Ethyl-3-({3-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl}amino)-5-(tetrahydro-2H-pyran-4-ylamino)-2-pyrazinecarboxamide is currently driven by its potential in treating various neurological and psychiatric disorders. Research trends indicate a focus on optimizing its pharmacokinetics and exploring new therapeutic applications. The increasing demand for personalized medicine and drug repurposing is also likely to influence market dynamics.

Waste containing this compound should be collected in appropriate containers, labeled with the chemical's name and CAS number, and stored in a secure and well-ventilated area. Proper disposal methods include incineration or professional waste disposal services. Environmental protection precautions include ensuring no spillage and using personal protective equipment. Always adhere to local and national regulations for the safe handling and disposal of hazardous waste.